pillbase.ru

DALFAMPRIDINE

Active substance: dalfampridine

TABLET, EXTENDED RELEASE · DALFAMPRIDINE 10 mg/1

United StatesActive

Marketing holder: Micro Labs Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Fampridine Accord
    Fampridine
    EMEA/H/C/005359
    Accord Healthcare S.L.U.
  • Fampyra
    Fampridine
    EMEA/H/C/002097
    Merz Therapeutics GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5b29-73fc-b37a-78816d0eeab9,01a1208d-839c-7171-b2e6-4ef27f89e816,01a12091-7027-76a6-80ed-444d810f1dc2,01a12092-5301-770b-82f6-7d640b7812ea,01a12093-a35c-74c6-92c8-265df8e82372;count=11 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
42571-275
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 42571-275 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 42571-275 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 42571-275 · Verified 2026-10-09 · open in source